Operating Lease, Right-of-Use Asset of IO Biotech, Inc. from 01 Jan 2022 to 30 Sep 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of lessee's right to use underlying asset under operating lease.
Summary: IO Biotech, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2022 to 30 Sep 2025.
IO Biotech, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2025 was $1,302,000, a 28% decline year-over-year.
Source SEC data: View on sec.gov

Operating Lease, Right-of-Use Asset, Quarterly (USD)

Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

IO Biotech, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q3 2025	$1,302,000	-$512,000	-28%	30 Sep 2025	10-Q	14 Nov 2025	2025	Q3
Q2 2025	$1,470,000	-$466,000	-24%	30 Jun 2025	10-Q	14 Aug 2025	2025	Q2
Q1 2025	$1,585,000	-$507,000	-24%	31 Mar 2025	10-Q	14 May 2025	2025	Q1
Q4 2024	$1,725,000	-$534,000	-24%	31 Dec 2024	10-Q	14 Nov 2025	2025	Q3
Q3 2024	$1,814,000	-$553,000	-23%	30 Sep 2024	10-Q	12 Nov 2024	2024	Q3
Q2 2024	$1,936,000	-$598,000	-24%	30 Jun 2024	10-Q	13 Aug 2024	2024	Q2
Q1 2024	$2,092,000	-$500,000	-19%	31 Mar 2024	10-Q	14 May 2024	2024	Q1
Q4 2023	$2,259,000	-$234,000	-9.4%	31 Dec 2023	10-K	31 Mar 2025	2024	FY
Q3 2023	$2,367,000	-$245,000	-9.4%	30 Sep 2023	10-Q	13 Nov 2023	2023	Q3
Q2 2023	$2,534,000	+$386,000	+18%	30 Jun 2023	10-Q	11 Aug 2023	2023	Q2
Q1 2023	$2,592,000	+$344,000	+15%	31 Mar 2023	10-Q	11 May 2023	2023	Q1
Q4 2022	$2,493,000	+$193,000	+8.4%	31 Dec 2022	10-K	05 Mar 2024	2023	FY
Q3 2022	$2,612,000			30 Sep 2022	10-Q	09 Nov 2022	2022	Q3
Q2 2022	$2,148,000			30 Jun 2022	10-Q	11 Aug 2022	2022	Q2
Q1 2022	$2,248,000			31 Mar 2022	10-Q	16 May 2022	2022	Q1
Q4 2021	$2,300,000			01 Jan 2022	10-K	05 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.